Frequency of anemia and its association with outcome (sustained virological response) in patients of chronic hepatitis C Geno 3, treated with standard interferon alpha 2a and ribavirin
Journal Title: Pakistan Journal of Pharmacology - Year 2012, Vol 29, Issue 2
Abstract
Chronic Hepatitis C is one of the leading cause of chronic liver disease globally. The past two decades have seen many advances in Hepatitis C treatment. Despite these advances side effects of treatment are common. Hematological complications of treatments can result in treatment cessation and suboptimal results We observed the development of haematological side effects chiefly anaemia and its effect on SVR in a cohort of 240 patients. The mean Haemoglobin at baseline was 13.2 gm, range 10.9-16, SD=0.8. At 6 months the mean Haemoglobin was 10.6 gm (7-11gm) SD=0.7. Clinically significant anaemia defined as haemoglobin of less than 10 gm/dl occurred in 56 % (n=134) of patients. Out of these 36% (n=48) were males and 64% (n=86) were females. More than 69 % of the total cohort (n=165 pts) experienced a drop of Hb of ≥ 3 gm/dl. Hemoglobin decreased by 2.8 gm at week 4 in 44% of patients and by 3.5 gm in 25% of patients at 3 months. A decrement in Hb of upto 2.9% was seen at the end of 6 months of treatment.The P value is < 0.05, this difference is considered to be statistically significant. Overall SVR was 71%. SVR rates in those who developed anaemia was 76% and in those who did not develop anaemia was 68%. The P value equals 0.5, this difference is considered to be not statistically significant. Anaemia is a frequent complication of interferon and ribavirin treatment for chronic hepatitis C and needs management with dose reduction and erythropoietin to optimize SVR. Erythropoietic agents are effective in treating anemia, preventing ribavirin dose reduction and improving patient’s quality of life.
Authors and Affiliations
Musarrat Iqbal, Akbar Waheed, Saleem Qureshi
Keywords
Related Articles
- EP ID EP98464
- DOI -
- Views 137
- Downloads 0
To study the efficacy and safety of combination treatment using allopurinol and fenofibrate in patients with hyperuricemia
Allopurinol is the most frequently used antihyperuricemic drug. Fenofibrate, a derivative of fibric acid, is commonly used in the treatment of hyperlipidemia. Fenofibrate treatment has been shown to decrease serum urate...
Development of Rp-HPLC method for fexofenadine determination in tablet formulations and development of dissolution method
Fexofenadine hydrochloride is a piperidine derivative. It is indicated to relive signs and symptoms that are related with seasonal allergic rhinitis, such as rhinorrhea, sneezing, nose, throat and itchy eyes. In the pres...
Frequency of anemia and its association with outcome (sustained virological response) in patients of chronic hepatitis C Geno 3, treated with standard interferon alpha 2a and ribavirin
Chronic Hepatitis C is one of the leading cause of chronic liver disease globally. The past two decades have seen many advances in Hepatitis C treatment. Despite these advances side effects of treatment are common. Hemat...
The prevalence of cardiovascular diseases and role of protective measures among hajj pilgrims 1432 (2011)
This descriptive study was undertaken to determine the pattern of Cardiac diseases among hospitalized patients during hajj 2011 because the world is now facing the growing prevalence of cardiac diseases. The aim of thi...
Prevention of succinylcholine induced muscular effects by pretreatment with rocuronium
We have studied in 60 patients undergoing minor muscle cutting surgeries under general anesthesia, the effectiveness and sequelae of pretreatment with rocuronium for reducing muscular side effects after succinylcholine a...